Years of research by world class scientists
Our Mission
To unlock the benefits of nature and improve the lives of billions

Our Team
The beating heart of Nuritas is our incredibly passionate team.
We have an international team comprising over 16 different nationalities with offices in Dublin and Boston. We are also very proud of our gender balance with 50% women and men across the team.
Our Data Scientists, Biologists, AI Engineers, Chemists, Commercial and Operations teams bring innovation, passion and flexibility to their work every day.
860
593
65
Our history
- Nuritas Founded2014
- Nuritas raises $5M in seed capital2016Full integration of AI system and wet lab
- $20m raised through Series A2017Collaboration with BASF
Johnson & Johnson innovation award
- €30m debt funding from EIB2018Collaboration with Pharmavite
- Collaboration with Nestle2019Launch of PeptAIde, first AI discovered health product
- Launch of Nuritas ingredient product range2020
Our Teams
Scientific advisory board
Team
Some of Nora’s publications have been placed in a library of the top 2% of published articles in the fields of biology and medicine.
Throughout her career, Nora’s ambition has been to disrupt the status quo in areas that have been void of technology by introducing new ways of thinking, big data, and new algorithms.
Previous to Nuritas™, Nora was the first scientist to show gene transfer between multi-cellular species. This groundbreaking find put into question many of the phylogenetic methods currently in use today.
Nora has developed a multitude of innovative software throughout her research career that are used to this day by research institutes and companies in over 70 countries. Nora has led international research teams around the world, in both academic and industrial settings, and has a proven record in new health-benefiting molecule discovery and commercialisation.
Over the next few years, Nora plans to lead the Nuritas™ team in their goal of reaching billions of people with their life-changing ingredients.


Prior to her PhD, Sanja worked in the National Centre for Poisoning Control in Serbia. She moved to the USA for her PhD in Analytical Chemistry at the University of Kentucky (UK). There Sanja applied molecular biology techniques for biomarker assay development. She also worked on a pipeline for qualitative and quantitative proteomics where she developed an array of novel strategies to apply state of the art bottom-up proteomic and mass spectrometry approaches to the PTM identification.
Sanja moved to Ireland in 2015 joining Alltech, where she built, from the ground-up, a new lab for mycotoxin testing and received ISO 17025 accreditation. She joined Nuritas in 2017 as Head of Proteomics and Analytical Science.
years of experience in scientific research. Before joining Nuritas, Aoife was a EMBO Long
Term Fellow in the Integrative Genomics of Ageing Group in the University of Liverpool.
There, she was the lead on an international collaboration between Liverpool and Duke
University that identified novel single nucleotide polymorphisms that differentially affect
mortality in cancer patients with age. This research is key in the development of age-
specific prognostic biomarkers and personalized therapies. She has also authored other
research on the role of gene expression changes, gene duplication patterns and a new
approach for interpreting random forest models.
Aoife joined Nuritas in 2017 and has been key in conceiving, developing and leading the
maintenance of a large, complex database of curated biological data. During her tenure, she
has overseen the amount of experimental information available to our proprietary
predictive platform to increase by >1000%.
Owen joined Nuritas in 2020, having spent the previous 5 years as CFO of a Global eCommerce and AI Technology start-up. Prior to that, he was CFO of an international FMCG business with customers such as Tesco, M&S, Aldi and Lidl. He also served time as the Finance Director of an IT multinational services company with major global customers such as Dell, Intel and Apple.
Owen has an MBA from Dublin City University and also completed the Stanford Graduate School of Business Strategic Leadership for CFO's programme.
Owen has negotiated Long Term Agreements with some of the largest Technology and Retail Companies in the world and has extensive M&A and fundraising experience to fund global growth.
brings over 17 years’ experience in R&D and industrial biotechnology. Mark’s previous
research has focused on the development and characterisation of novel ingredients for
the crop and agrifeed sectors. This largely revolved around the use of microbial-derived
components and peptide chelated minerals to deliver innovative solutions to the
marketplace, while enhancing the quality and nutritional value of foodstuffs. Prior to
joining Nuritas, Mark was in Alltech, where he held several positions, the last of which
was as Platform Lead for the Crop Science Research Programme.
Prior to joining Nuritas, Bernard was a senior adviser at Granahan McCourt, a private investment firm focused on connecting people to innovation in technologically underserved areas of the world. He served as General Counsel of enet, the leading wholesale communications provider in Ireland, and sat on the boards of several other entities in which Granahan McCourt held investments.
Previously, Bernard held leadership roles with global communications firms Level 3 and Global Crossing. He was General Counsel at ComReg, regulator of the communications and postal sectors in Ireland, and held various roles at William Fry, a leading international law firm.
Her expertise includes designing clinical trials to evaluate dietary ingredient health benefits, incorporating nutrition into business strategy, and developing scientific regulatory dossiers for the US, EU and Asia. Barbara has a record of translating science into competitive product positioning opportunities internationally.

Dr Hansel Gomez, PhD
Also known as:


Heidi Carolinn Davis, MSc
Also known as:


Dr Kathy Kennedy, PhD
Also known as:


Stephanie Nolan, MSc
Also known as:


Dr Rory Casey, PhD
Also known as:


Dr Niamh Maire Mohan, PhD
Also known as:


Dr Alisha McLoughlin, PhD
Also known as:


Sweeny Chauhan, MSc
Also known as:


Shane Whelan
Also known as:


Michelle McCarthy, Msc
Also known as:


Stephen Murphy
Also known as:


Alish Kerr, MSc
Also known as:


Dr Jean Manguy, PhD
Also known as:


Adam Cully, MSc
Also known as:


Thomas Ball
Also known as:


Lorna Boyce
Also known as:


Wellington Omorodion
Also known as:

Investors





Prior to founding NPC in 2014, Matthieu was with Everest Capital, a large independent investment firm with offices in the US and in Singapore, for over 16 years. At Everest Capital, he was a Senior Managing Director and the Director of Research as well as a member of the Executive and Investment committees. Prior to Everest, Matthieu was with Banque Paribas, in Hong Kong, New York, Taipei and Paris.
Matthieu has a postgraduate degree in Corporate Finance from Université Paris Dauphine and has a graduate degree from Institut d’Etudes Politiques de Paris (Sciences Po).
Prior to forming Sandbox, Nick led the buyout and served as CEO of The NutraSweet Company. As a senior executive at Monsanto, he led the Nutrition and Consumer Products division, overseeing NutraSweet, the consumer Lawn and Garden Business, and Kelco food ingredients business. Nick also served as a Senior Vice President and Advisor to the Board of Directors at Monsanto.
Previously, Nick held senior executive positions at Searle and has experience with Masonite Corporation and Baxter. He has lived and worked in several countries, including Kuwait, Switzerland and France. Nick has also been involved with numerous civic and commercial organizations. Nick holds a B.S. in Political Science from Northern Illinois University and an MBA from DePaul University.

Ali Partovi

Bono

Edge
